Literature DB >> 25877961

Malaria resistance to non-artemisinin partner drugs: how to reACT.

Donelly A van Schalkwyk1, Colin J Sutherland2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25877961     DOI： 10.1016/S1473-3099(15)70080-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  10 in total

1.  Reply to Plucinski et al., "Interpreting Data from Passive Surveillance of Antimalarial Treatment Failures".

Authors:  Colin J Sutherland; Effrossyni Gkrania-Klotsas; Peter L Chiodini
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

Review 2.  Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.

Authors:  Valentine Duru; Benoit Witkowski; Didier Ménard
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

3.  Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model.

Authors:  Juliana M Sá; Sarah R Kaslow; Michael A Krause; Viviana A Melendez-Muniz; Rebecca E Salzman; Whitney A Kite; Min Zhang; Roberto R Moraes Barros; Jianbing Mu; Paul K Han; J Patrick Mershon; Christine E Figan; Ramoncito L Caleon; Rifat S Rahman; Tyler J Gibson; Chanaki Amaratunga; Erika P Nishiguchi; Kimberly F Breglio; Theresa M Engels; Soundarapandian Velmurugan; Stacy Ricklefs; Judith Straimer; Nina F Gnädig; Bingbing Deng; Anna Liu; Ababacar Diouf; Kazutoyo Miura; Gregory S Tullo; Richard T Eastman; Sumana Chakravarty; Eric R James; Kenneth Udenze; Suzanne Li; Daniel E Sturdevant; Robert W Gwadz; Stephen F Porcella; Carole A Long; David A Fidock; Marvin L Thomas; Michael P Fay; B Kim Lee Sim; Stephen L Hoffman; John H Adams; Rick M Fairhurst; Xin-Zhuan Su; Thomas E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-19       Impact factor: 11.205

4.  Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.

Authors:  Chanaki Amaratunga; Pharath Lim; Seila Suon; Sokunthea Sreng; Sivanna Mao; Chantha Sopha; Baramey Sam; Dalin Dek; Vorleak Try; Roberto Amato; Daniel Blessborn; Lijiang Song; Gregory S Tullo; Michael P Fay; Jennifer M Anderson; Joel Tarning; Rick M Fairhurst
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

5.  Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria.

Authors:  Rashad Abdul-Ghani; Mohammed A K Mahdy; John C Beier; Leonardo K Basco
Journal:  Infect Dis Poverty       Date:  2017-02-06       Impact factor: 4.520

6.  Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: a protocol to investigate safety, efficacy and adherence.

Authors:  Henk Dfh Schallig; Halidou Tinto; Patrick Sawa; Harparkash Kaur; Stephan Duparc; Deus S Ishengoma; Pascal Magnussen; Michael Alifrangis; Colin J Sutherland
Journal:  BMJ Glob Health       Date:  2017-08-30

7.  pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom.

Authors:  Colin J Sutherland; Paul Lansdell; Mandy Sanders; Julian Muwanguzi; Donelly A van Schalkwyk; Harparkash Kaur; Debbie Nolder; Julie Tucker; Hayley M Bennett; Thomas D Otto; Matthew Berriman; Trupti A Patel; Roderick Lynn; Effrossyni Gkrania-Klotsas; Peter L Chiodini
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

8.  Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.

Authors:  Jesmin Permala Lohy Das; Myat P Kyaw; Myat H Nyunt; Khin Chit; Kyin H Aye; Moe M Aye; Mats O Karlsson; Martin Bergstrand; Joel Tarning
Journal:  Malar J       Date:  2018-03-23       Impact factor: 2.979

Review 9.  Artemisinin susceptibility in the malaria parasite Plasmodium falciparum: propellers, adaptor proteins and the need for cellular healing.

Authors:  Colin J Sutherland; Ryan C Henrici; Katerina Artavanis-Tsakonas
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

10.  Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa.

Authors:  Hannah C Slater; Jamie T Griffin; Azra C Ghani; Lucy C Okell
Journal:  Malar J       Date:  2016-01-06       Impact factor: 2.979
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.